Can SARS‐CoV‐2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review

INTRODUCTION: Although the COVID‐19 vaccination is deemed safe, exact incidence and nature if adverse effects, particularly dermatological ones, are still unknown. OBJECTIVE: To describe the demographic, clinical, morphological characteristics, outcomes, and timing of development of herpes zoster to...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Hardik D., Sharma, Kamal, Shah, Anchal, Patoliya, Jaimini, Patil, Anant, Hooshanginezhad, Zahra, Grabbe, Stephan, Goldust, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Covid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597588/
https://www.ncbi.nlm.nih.gov/pubmed/34719084
http://dx.doi.org/10.1111/jocd.14521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597588/
https://www.ncbi.nlm.nih.gov/pubmed/34719084
http://dx.doi.org/10.1111/jocd.14521

Ejemplares similares